![]() |
市场调查报告书
商品编码
1891503
牙科骨移植替代材料市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2024-2032 年)Dental Bone Graft Substitutes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast, 2024-2032 |
||||||
随着牙科专业人士越来越依赖生物基和合成材料来恢復骨量和支持植牙手术,全球牙科骨移植替代材料市场持续扩张。根据最新数据,受牙周病、牙齿脱落和牙齿断裂盛行率上升的推动,该市场在 2024 年的价值将达到 3.078 亿美元。预计到 2025 年,该市场将达到 3.281 亿美元,这主要得益于植牙技术的日益普及和先进植牙材料的出现。到 2032 年,全球市场预计将显着增长至 5.294 亿美元,这反映了再生生物材料的广泛应用和全球手术量的增长。
牙科骨移植替代材料包括同种异体移植、合成材料、脱矿骨基质和异种移植,旨在修復缺失或受损的骨组织。这些替代材料模拟天然骨骼的结构并促进再生,因此在齿槽骨增高术、上颚窦提升术和植体稳定等手术中至关重要。
市场概览与区域趋势
2024年,北美维持领先地位,市占率达47.69%(价值1.468亿美元)。这主要得益于牙科植牙手术量大、患者意识高以及新型植牙解决方案的不断涌现。包括美国FDA批准的3D列印再生骨移植材料在内的创新技术进一步巩固了该地区的领先地位。
欧洲占第二大市场占有率,这得益于其强大的研发投入和不断增加的策略性收购。像 Geistlich Pharma AG 这样的公司正透过收购和联合培训专案拓展业务,进一步促进产品推广。
预计亚太地区在预测期内将达到最高的复合年增长率。快速成长的驱动因素包括牙科疾病的增加、人口老化促使齿槽骨再生需求上升以及製造商投资的增加。由于手术量增加和技术进步,日本、中国和印度正在成为关键市场。
拉丁美洲以及中东和非洲地区的市场接受度也在提高,这得益于医疗基础设施的改善、病患意识的增强以及医疗旅游业的蓬勃发展。
主要市场驱动因子
根据世界卫生组织 (WHO) 的数据,全球牙周病和龋齿发病率的上升显着推动了对骨移植手术的需求。 5.14亿儿童患有乳牙龋齿,20亿成年人患有恆牙龋齿。各公司持续研发先进的生物相容性骨移植替代材料。例如,2024年2月,Geistlich Pharma推出了Varos Granules,这是一种脱矿异体骨移植材料,适用于各种牙科应用。
一个值得关注的市场趋势是,可根据患者解剖结构量身定制的3D列印再生植入物正被迅速采用。这些创新技术能够改善骨骼完整性和临床疗效。 Desktop Metal公司的CMFlex 3D列印植入物于2022年12月获得美国FDA批准,这显示牙科领域对先进技术的接受度正在不断提高。
旨在拓展生物材料产品组合併改善再生医学产品可近性的合作正在增强市场实力。 Biocomposites 于 2023 年收购 Artus,以及 Zimmer Biomet 与 RTI Surgical 合作支持美国退伍军人,都是业界合作如何加速产品推广和临床应用的良好例证。
市场挑战
儘管成长前景强劲,但挑战依然存在。一些国家对植入手术的保险覆盖范围限制增加了患者的自付费用,并影响了产品的普及率。此外,免疫反应、骨诱导性有限和骨形成不足等潜在风险可能会限制某些地区的临床应用。严格的监管准则进一步延缓了产品审批和市场渗透。
依产品类型
2024年,脱矿骨基质(DBM)市场占有率最大,这主要得益于对需要高级骨再生技术的种植手术的高需求。同时,由于合成骨移植替代品易于取得、成本效益高且具有良好的生物相容性,预计其成长速度最快。
依型态
2024年,颗粒状骨移植替代物将主导市场,这主要归功于其促进成骨细胞附着和刺激骨形成的表面特性。由于产品不断创新,糊状和块状骨移植替代物的市场占有率预计将会扩大。
依最终使用者
2024年,个体执业者将引领市场,这主要得益于患者的强烈偏好以及众多开展骨移植手术的独立牙科诊所。同时,由于集中采购和手术数量的增加,预计牙科服务机构/集团诊所将迎来快速增长。
The global dental bone graft substitutes market continues to expand as dental professionals increasingly depend on biologic and synthetic materials to restore bone volume and support implant procedures. According to the latest data, the market was valued at USD 307.8 million in 2024, driven by the rising prevalence of periodontal disease, tooth loss, and dental fractures. In 2025, the market is projected to reach USD 328.1 million, supported by growing adoption of implant dentistry and availability of technologically advanced grafting materials. By 2032, the global market is expected to grow significantly to USD 529.4 million, reflecting the expanding use of regenerative biomaterials and higher procedural volumes worldwide.
Dental bone graft substitutes include allografts, synthetic materials, demineralized bone matrices, and xenografts designed to restore missing or damaged bone tissue. These substitutes mimic the structure of natural bone and promote regeneration, making them essential in procedures such as ridge augmentation, sinus lifts, and implant stabilization.
Market Overview and Regional Performance
North America dominated the market in 2024 with a 47.69% share, equivalent to USD 146.8 million, driven by a high volume of dental implant surgeries, strong patient awareness, and continuous launches of new grafting solutions. Innovative technologies, including U.S. FDA-approved 3D-printed regenerative bone grafts, continue to strengthen the region's leadership position.
Europe held the second-largest share, supported by strong R&D investments and an increasing number of strategic acquisitions. Companies such as Geistlich Pharma AG are expanding their presence through acquisitions and collaborative training programs, further enhancing product adoption.
The Asia Pacific region is expected to record the highest CAGR during the forecast period. Rapid growth is driven by increasing dental disorders, a rising geriatric population needing alveolar bone regeneration, and expanding investments by manufacturers. Japan, China, and India are emerging as key markets due to increasing procedural volumes and growing technological advancements.
Latin America and the Middle East & Africa are also experiencing growing adoption due to improving healthcare infrastructure, rising patient awareness, and expanding medical tourism.
Key Market Drivers
The increasing global incidence of periodontal disease and tooth decay-such as 514 million children with primary decay and 2 billion adults affected by permanent decay, according to the WHO-has significantly increased the demand for bone grafting procedures. Companies continue to launch advanced, more biocompatible graft substitutes. For example, in February 2024, Geistlich Pharma AG introduced Vallos granules, a demineralized allograft designed for various dental applications.
A notable trend in the market is the rapid adoption of 3D-printed regenerative grafts, which can be customized to patient-specific anatomy. These innovations enhance bone integration and clinical outcomes. The U.S. FDA approval of Desktop Metal's CMFlex 3D-printed graft in December 2022 demonstrates the growing acceptance of advanced technologies in dentistry.
The market is strengthened by collaborations aimed at expanding biomaterial portfolios and improving access to regenerative products. The 2023 Biocomposites acquisition of Artoss, and partnerships between Zimmer Biomet and RTI Surgical to support U.S. veterans, underscore how industry alliances drive product availability and clinical adoption.
Market Challenges
Despite strong growth prospects, challenges persist. Limited reimbursement coverage for grafting procedures in several countries increases out-of-pocket costs for patients, affecting adoption rates. In addition, potential risks-such as immunogenic reactions, limited osteoinductive properties, or inadequate bone formation-may restrict clinical use in some regions. Strict regulatory guidelines further slow product approvals and market penetration.
By Product Type
In 2024, the demineralized bone matrix (DBM) segment held the largest share, driven by high demand for implant procedures requiring enhanced bone regeneration. Meanwhile, synthetic bone graft substitutes are expected to grow fastest due to their availability, cost-effectiveness, and high biocompatibility.
By Form
Granules dominated the market in 2024, favored for their surface texture that promotes osteoblast attachment and stimulates osteogenesis. Putty and block forms are expected to expand with ongoing product innovations.
By End-User
Solo practices led the market in 2024, supported by strong patient preference and the high number of independent dental clinics performing grafting procedures. DSO/group practices are anticipated to grow rapidly due to centralized procurement and expanding procedural volumes.
Conclusion
The dental bone graft substitutes market is on a strong upward trajectory-progressing from USD 307.8 million in 2024 to USD 328.1 million in 2025, and reaching USD 529.4 million by 2032. With rising dental implant adoption, increased availability of advanced materials, and accelerating technological innovation, the market will continue to advance global regenerative dentistry and improve clinical outcomes for millions of patients.
Segmentation By Product Type
By Form
By End-user
By Regin